Endocrine Abstracts

Introduction: COVID-19 in Kosovo was introduced in March 2020 as a global pandemic started in Wuhan, China in December 2019. The link between COVID-19 and diabetes was seen in the first cases but was if this disease is interfering in other endocrine glands was still unclear. In May 2020 we found the first case of subacute thyroid immediately after COVID-19 which case trigger us for further observation of its spread.Aim: To investigate the clinical forms ...

Introduction: Obesity today is a growing epidemic throughout the world. With weight gain, the risk of type 2 diabetes and hypertension increases. With the approval of GLP-1 RA (semaglutide) by the FDA in June 2021 for weight reduction, a big push was given regarding the possibilities of obesity and especially for people at high risk of developing type 2 diabetes.Aim: To analyze the impact of semaglutide on insulin resistance and weight loss in patients w...

Background and aim: Hyperglycemia is an important pathogenetic factor, which causes abnormalities at the cardiac myocyte level, leading to structural and functional abnormalities and diabetic cardiomyopathy (DCM). It has been proposed that DCM could also occur as a consequence of other metabolic alterations. Adiponectin concentration is negatively associated with obesity, insulin resistance (IR), oxidative stress and endothelial dysfunction. It can be considered as a predictiv...